Protein that can help treatment of leukemia identified, UCLA scientists upbeat – International Business Times, Singapore Edition
By daniellenierenberg
Cancer | One of the most common disease in the world
In what may prove as a breakthrough in the treatment of leukaemia and other blood diseases, scientists at UCLA have discovered a protein produced by a gene known as MLLT3 and its connection to the multiplication of human blood stem cells.
The discovery which was published in a study is very much significant as cancers such as leukaemia can be effectively treated using blood stem cells, also known as Hematopoietic stem cells (HSCs), produced outside the human body and could serve as an alternative to existing treatment options such as bone marrow transplants.
Self-renewal is the process by which stem cells divide to create more cells. The study focused on a specific type of the kind: Hematopoietic stem cells (HSCs) which are present within the bone marrow where along with self-renewal, they also produce different types of blood cells such as red and white by transforming into them.
Placing HSCs in laboratory dishes after their removal from the bone marrow causes then to lose their ability to self-renew, and they either transform into other blood types or perish. It is this process that the scientists studied. Through a series of steps, the researchers studied the genes that shutdown as the cells lost their capacity to self-renew.
They discovered that the HSCs' ability to self-renew corresponded with the expression of a gene called MLLT3. They also found that MLLT3 generated a protein that instructed HSCs to retain their capacity to self-renew. As the cells divide, the protein works along with other regulatory proteins to keep vital components of the HSCs' functioning.
Employing a viral vector the researchers tried to ascertain if maintaining the MLLT3 protein levels in lab dishes would help improve the self-renewing abilities of HSCs. A viral vector is a specially designed virus that transfers genetic information to the nucleus of a cell without giving rise to a disease. Using the vector, the scientists introduced an active MLLT3 gene into HSCs. They found that there was nearly a twelvefold multiplication of working HSCs in lab dishes.
"If we think about the amount of blood stem cells needed to treat a patient, that's a significant number," said Dr. Hanna Mikkola, a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, and senior author of the study, to the UCLA Newsroom.
The UCLA scientists observed that the use of 'small molecules' organic compounds that help in the multiplication of human HSCs, improved self-renewal in general. However, the cells were unable to maintain stable MLLT3 levels and did not perform well when implanted into mice.
"Our method, which exposes blood stem cells to the small molecules and also inserts an active MLLT3 gene, created blood stem cells that integrated well into mouse bone marrow, efficiently produced all blood cell types and maintained their self-renewing ability," said Vincenzo Calvanese, a UCLA project scientist and the study's co-corresponding author, to the UCLA Newsroom.
The team noted that the self-renewal of HSCs caused by MLLT3 was at a safe rate. This means that they did not acquire potent characteristics such as mutation or excessive multiplication, or the production aberrant cells that can cause leukaemia.
Determining which proteins and constituents within the DNA of the HSCs affect the activation and deactivation of MLLT3 is the next step for the team. Also, understanding the regulation of the process using components in the lab dishes is another step. The information gathered may help find ways in which MLLT3 could be switched on and off without employing a viral vector.
Read more from the original source:
Protein that can help treatment of leukemia identified, UCLA scientists upbeat - International Business Times, Singapore Edition
- CHMP Issues Positive Opinion Recommending DARZALEX (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple... - December 14th, 2019
- Blinatumomab May Become New Standard of Care for Post-Reinduction Therapy in Young Patients With B-ALL - Cancer Therapy Advisor - December 12th, 2019
- LentiGlobin Gene Therapy Continues to Show Promising Results in SCD, Updated Trial Data Shows - Sickle Cell Anemia News - December 12th, 2019
- Science Fiction Becoming Reality - Reporter Magazine - December 12th, 2019
- Novartis completes certification of initial sites in Ontario for first approved Canadian CAR-T therapy, Kymriah (tisagenlecleucel)[i] - Canada... - December 12th, 2019
- New Mechanism of Bone Maintenance and Repair Discovered - Technology Networks - December 12th, 2019
- Deacon Butch King learns to accept the 'gift' of cancer - Arkansas Catholic - December 12th, 2019
- GIMEMA AML1310 trial of risk-adapted, MRD-guided therapy for young patients with newly diagnosed AML - AML Global Portal - December 12th, 2019
- Global Blood and Bone Marrow Cancer Treatment Market Trends & Analysis During the Forecast Period, 2019-2027 - ResearchAndMarkets.com - Business... - December 10th, 2019
- Sickle Cell Disease: Ex Vivo Cell Therapy Shines in Early Study - MedPage Today - December 10th, 2019
- 2019: the year gene therapy came of age - Japan Today - December 10th, 2019
- Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American... - December 10th, 2019
- Bone Marrow Aspirate Concentrates Market to Expand at an Outstanding CAGR of 5% from 2017 to 2025 - VaporBlash - December 10th, 2019
- Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting - Business Wire - December 9th, 2019
- Autoimmune Technologies Announces New Subsidiary to Develop Novel Antibody and Allogeneic Somatic Stem Cell Therapeutics For the Treatment of Invasive... - December 9th, 2019
- Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting &... - December 9th, 2019
- Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to... - December 9th, 2019
- Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug... - December 9th, 2019
- Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency -... - December 9th, 2019
- Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies - PRNewswire - December 9th, 2019
- ASH 2019: Second-gen CAR T-Cell Therapy Overcome Resistance, Reduce Toxicity and Simplify Treatment - OncoZine - December 9th, 2019
- Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers - BioSpace - December 9th, 2019
- Hematopoietic Stem Cell Transplantation (HSCT) Market Global Industry Study, Trends, Overview, Insights And Outlook 2019-2025 - Markets Gazette 24 - December 9th, 2019
- Aprea Therapeutics Presents Results From U.S. Phase Ib/II Clinical Trial of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic... - December 9th, 2019
- MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual... - December 9th, 2019
- Company Profile for Jasper Therapeutics, Inc - Business Wire - December 8th, 2019
- 3-year-old needs bone marrow transplant to survive, says UAE-based father - Gulf News - December 8th, 2019
- Sickle Cell Anemia Patient Becomes First Person in the US to Have Her Genes Edited With CRISPR - Interesting Engineering - December 8th, 2019
- Jasper Therapeutics launches out of Stanford with new approach to stem cell treatment - Endpoints News - December 8th, 2019
- Mount Sinai Joins Progressive MS Trial of NurOwn Cell Therapy - Multiple Sclerosis News Today - December 8th, 2019
- Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers - GlobeNewswire - December 8th, 2019
- IFN-: The T cell's license to kill stem cells in the inflamed intestine - Science - December 6th, 2019
- Cellex Opens New Plant to Manufacture Innovative Cell Therapy Products for Cancer - Yahoo Finance - December 6th, 2019
- Rocket Pharmaceuticals Announces First Patient Treated in Global Registrational Phase 2 Study of RP-L102 Process B for Fanconi Anemia - BioSpace - December 6th, 2019
- 2019: the year gene therapy came of age - FRANCE 24 - December 5th, 2019
- As per new Study on Stem Cell Therapy Market 2019 Future Strategy, Analysis and Prediction by Leading Manufacturers, its Application and Types... - December 5th, 2019
- Bone Marrow Aspirate Concentrates Market is Anticipated to Expand at a CAGR of 5% from 2017 to 2025 - Drnewsindustry - December 5th, 2019
- Stem Cell Therapy Market Size, Share, Trends, and Opportunity Analysis by 2017 - 2025 - The Market Expedition - December 5th, 2019
- First UK Clinical Trial Site Open for Recruitment of Diabetic Patients with Chronic Limb-Threatening Ischemia Using Novel Patient-Specific... - December 5th, 2019
- Stem of the problem | Columns | Journal Gazette - Fort Wayne Journal Gazette - December 3rd, 2019
- Howard University athlete makes the call to donate stem cells - WTOP - December 3rd, 2019
- Blood and Bone Marrow Cancer Treatment Market Is Expected To Reach US$ 74.9 Bn by 2027 - Credence Turbine - December 3rd, 2019
- Howard University Student Gives a Stranger the Greatest Gift for the Holidays: Life - Howard Newsroom - December 3rd, 2019
- Wallsend dad who called on the public for stem cells for his son scoops top Anthony Nolan Award - Chronicle Live - December 3rd, 2019
- Artist's first exhibition following stem cell transplant - The Westmorland Gazette - December 1st, 2019
- The Best Thanksgiving - GlobeNewswire - December 1st, 2019
- Researchers discover a stem cell therapy that can help heal injured heart - ANI News - November 29th, 2019
- Brave Scots tot born with two types of leukaemia to spend Christmas at home after second stem cell transplant - The Scottish Sun - November 29th, 2019
- Researchers Find a Way to Collect Elusive Blood Stem Cells from Zebrafish - Mirage News - November 29th, 2019
- Systematic analysis and evaluation of Mesenchymal Stem Cells Market with share, growth rate, Forecasts to 2026 - WindStreetz - November 29th, 2019
- Despite illness, this Clemson fan will be tuned in for the Tigers-Gamecocks game - Greenville News - November 28th, 2019
- North-east toddler overcomes cancer after pioneering stem cell treatment - Press and Journal - November 28th, 2019
- Why ending HIV still rests on a working cure -- as well as prevention - MENAFN.COM - November 28th, 2019
- How the Packers' Za'Darius Smith brought joy and awareness to one woman's cancer fight - The Athletic - November 28th, 2019
- Researchers identify protein that governs human blood stem cell self-renewal - Newswise - November 27th, 2019
- Stem Cell Therapy Helps Broken Hearts Heal in Unexpected Way - Newswise - November 27th, 2019
- Translink in Armagh holding stem cell registration event in memory of Gavin McNaney - Armagh i - November 27th, 2019
- The Best Thanksgiving - Financialbuzz.com - November 27th, 2019
- Bone Marrow Aspirate Concentrates Market to Expand at an Outstanding CAGR of 5.0% from 2017 to 2025 - Statsflash - November 27th, 2019
- Stem Cell Banking Market Size, by Source (Placental Stem Cells), by Application (Personalized Banking Applications), by Service Type (Sample... - November 27th, 2019
- Discover The Latest Frontier in Anti-aging Medicine and 3 Regenerative Therapies You Should Know... - YourObserver.com - November 27th, 2019
- The Best Thanksgiving - Yahoo Finance - November 27th, 2019
- Scottish baby spent first Christmas in hospital after she was diagnosed with two types of cancer - Scotland on Sunday - November 27th, 2019
- Upstate SC toddler survives rare cancer and the risky procedure used to treat it - Greenville News - November 27th, 2019
- A primer: stem cell and regenerative medicine as 'the' emerging therapy - Chiropractic Economics - November 26th, 2019
- 2 Small-Cap Biotechs That Soared Last Week - Motley Fool - November 26th, 2019
- Thankful People -- 'He's gonna owe me big': Matthew McKee receives bone-marrow donation from twin sister Allee - Southeast Missourian - November 26th, 2019
- Stem Cell Banking Market to Expand Steadily in the Coming Years till 2018-2026 - Crypto Journal - November 26th, 2019
- BrainStorm Cell Therapeutics to make scientific presentations at the 30th International Symposium on ALS/MND - GlobeNewswire - November 26th, 2019
- Stem Cell Therapies Market research to Witness a Healthy Growth during 2015 2025 - Lake Shore Gazette - November 25th, 2019
- Vor Biopharma and MaxCyte announce clinical and commercial licence agreement for engineered hematopoietic stem cells to treat cancer - Pharmaceutical... - November 23rd, 2019
- Bone Marrow Processing System Market Incisive Insights Regarding Major Regions, Key Players And Opportunities Up To 2025 - Crypto News Byte - November 23rd, 2019
- Oliver and Elizabeth Hedgepeth column: Human donations are a gift of life - Richmond.com - November 23rd, 2019
- A Comprehensive Analysis of the Rheumatoid Arthritis Stem Cell Therapy Market Available in the Latest Report - Tech Admirers - November 23rd, 2019
- Anton Ferdinand: Giving back to other people is where I feel Im best - The Guardian - November 22nd, 2019
- Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells Derived from Adipose Tissue and Bone Marrow on Acute Myocardial Infarction... - November 22nd, 2019
- Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer -... - November 22nd, 2019
- Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Growth, Trends and Demands Research Report and Forecast 2025 - The Denton Chronicle - November 22nd, 2019
- Count it all joy, Part III: Coach Hill-Eley has his own cancer struggle - Montgomery Advertiser - November 22nd, 2019
- Fred Hutch at ASH: Latest CAR T data BCMA, CD19, CD20 plus new insights on transplantation, gene therapy and more - Newswise - November 22nd, 2019
